Skip to Main Content

Advertisement

Skip Nav Destination

Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Mol Cancer Ther (2023) 22 (2): 179–191.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Cui Li
  • Xiaokun Li
  • Ali Fan
  • Ning He
  • Dongmei Wu
  • Hongyan Yu
  • Kun Wang
  • Weijie Jiao
  • Xu Zhao
Biomedical Chromatography (2024) 38 (5)
  • Zihang Liu
  • Li Chen
  • Jifa Zhang
  • Jun Yang
  • Xue Xiao
  • Lianhai Shan
  • Wuyu Mao
European Journal of Medicinal Chemistry (2024) 272: 116475.
  • Eric Ubil
  • Kashif Rafiq Zahid
Frontiers in Immunology (2023) 14
Close Modal

or Create an Account

Close Modal
Close Modal